Onconova Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Onconova Therapeutics, Inc.‘s stocks are currently a part of 14 hedge funds’ portfolios, which represents 2.17% of the total amount of its stocks outstanding. This makes up a total of 453.27K shares of Onconova Therapeutics, Inc.. Compared to the previous quarter, the number fell by -70.79% or -1.09M shares fewer. As for the holding position changes, 14.29% (2) of current hedge fund investors increased the number of shares held, 28.57% (4) of current holders sold a part of the shares held, and 21.43% (3) closed the holdings completely. 3 hedge funds are new holders of Onconova Therapeutics, Inc. stock in Q1 2023, it is 21.43% of total holders.
Hedge funds holding Onconova Therapeutics (Q2 2018 – Q1 2023)
| Q2 2018 | 24 |
|---|---|
| Q3 2018 | 13 |
| Q4 2018 | 16 |
| Q1 2019 | 12 |
| Q2 2019 | 13 |
| Q3 2019 | 15 |
| Q4 2019 | 15 |
| Q1 2020 | 17 |
| Q2 2020 | 25 |
| Q3 2020 | 25 |
| Q4 2020 | 30 |
| Q1 2021 | 54 |
| Q2 2021 | 21 |
| Q3 2021 | 30 |
| Q4 2021 | 28 |
| Q1 2022 | 23 |
| Q2 2022 | 18 |
| Q3 2022 | 19 |
| Q4 2022 | 25 |
| Q1 2023 | 14 |
Hedge funds changes in Onconova Therapeutics positions (Q2 2018 – Q1 2023)
| Q2 2018 | 13 | 6 | 2 | 2 | 1 |
|---|---|---|---|---|---|
| Q3 2018 | 13 | 0 | 0 | 24 | -24 |
| Q4 2018 | 6 | 0 | 6 | 3 | 1 |
| Q1 2019 | 3 | 2 | 2 | 7 | -2 |
| Q2 2019 | 1 | 4 | 3 | 0 | 5 |
| Q3 2019 | 3 | 3 | 3 | 1 | 5 |
| Q4 2019 | 9 | 3 | 1 | 9 | -7 |
| Q1 2020 | 10 | 5 | 0 | 8 | -6 |
| Q2 2020 | 13 | 6 | 2 | 4 | 0 |
| Q3 2020 | 9 | 11 | 2 | 10 | -7 |
| Q4 2020 | 12 | 5 | 8 | 6 | -1 |
| Q1 2021 | 29 | 14 | 5 | 5 | 1 |
| Q2 2021 | 19 | 1 | 1 | 52 | -52 |
| Q3 2021 | 16 | 6 | 7 | 7 | -6 |
| Q4 2021 | 9 | 1 | 11 | 11 | -4 |
| Q1 2022 | 2 | 8 | 6 | 7 | 0 |
| Q2 2022 | 3 | 6 | 3 | 7 | -1 |
| Q3 2022 | 3 | 2 | 6 | 3 | 5 |
| Q4 2022 | 8 | 5 | 8 | 2 | 2 |
| Q1 2023 | 3 | 2 | 4 | 3 | 2 |
Hedge funds changes in Onconova Therapeutics stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 204,000 | 368,000 |
| Q4 2021 | 176,000 | 49,000 |
| Q1 2022 | 32,000 | 8,000 |
| Q2 2022 | 525,000 | 0 |
| Q3 2022 | 237,000 | 0 |
| Q4 2022 | 149,392 | 0 |
| Q1 2023 | 1,389,000 | 0 |